The Serum Institute of India (SII) is looking to launch the COVID-19 vaccine developed by the United States firm Novavax in India by September. The trials for the vaccine, called Covovax, are in the advanced stage of completion, SII CEO Adar Poonawalla said. Earlier this week, Novavax announced that the vaccine had been found over 90% effective against COVID-19. Here are more details.
source https://www.newsbytesapp.com/news/india/sii-ceo-adar-poonawalla-on-novavax-s-covovax-launch/story
source https://www.newsbytesapp.com/news/india/sii-ceo-adar-poonawalla-on-novavax-s-covovax-launch/story
إرسال تعليق